Presentation now available (to Primary clients only).
Significant changes have been made to the implementation of the clinical laboratory fee schedule (CLFS) since its introduction under the Protecting Access to Medicare Act (PAMA) in 2018. The “applicable laboratories” criteria have been expanded to include hospital laboratories engaged in outreach. The most recent period for data collection began on January 1, 2019, and laboratories may face significant challenges obtaining the needed data and defending the value of their laboratories.
Emeritus Assistant Professor
Laboratory Medicine and Pathology
Upon completion of this activity, participants should be able to:
The outreach forums are applicable to community hospital laboratory administrators, managers, directors, pathologists, outreach coordinators, marketing representatives, and sales managers.
The following types of credit are offered for this event:
State of California
State of Florida
To obtain credit:
1. Register for and participate in the program.
2. Complete the evaluation that will be sent to you after the program.
3. Generate and print your certificate(s).
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1 P.A.C.E® contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 1 contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the clinical laboratory sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1 contact hour.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.